AURA
Price
$5.39
Change
-$0.02 (-0.37%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
342.92M
132 days until earnings call
Intraday BUY SELL Signals
IDYA
Price
$33.14
Change
-$0.57 (-1.69%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.9B
132 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AURA vs IDYA

Header iconAURA vs IDYA Comparison
Open Charts AURA vs IDYABanner chart's image
Aura Biosciences
Price$5.39
Change-$0.02 (-0.37%)
Volume$1.9K
Capitalization342.92M
IDEAYA Biosciences
Price$33.14
Change-$0.57 (-1.69%)
Volume$9.83K
Capitalization2.9B
AURA vs IDYA Comparison Chart in %
AURA
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AURA vs. IDYA commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and IDYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (AURA: $5.41 vs. IDYA: $33.70)
Brand notoriety: AURA and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 61% vs. IDYA: 62%
Market capitalization -- AURA: $342.92M vs. IDYA: $2.9B
AURA [@Biotechnology] is valued at $342.92M. IDYA’s [@Biotechnology] market capitalization is $2.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileIDYA’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • IDYA’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 3 TA indicator(s) are bullish while IDYA’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 3 bullish, 5 bearish.
  • IDYA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -4.42% price change this week, while IDYA (@Biotechnology) price change was +5.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

AURA is expected to report earnings on Mar 31, 2026.

IDYA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.9B) has a higher market cap than AURA($343M). IDYA YTD gains are higher at: 31.128 vs. AURA (-34.185). AURA has higher annual earnings (EBITDA): -107.51M vs. IDYA (-380.2M). IDYA has more cash in the bank: 670M vs. AURA (177M). AURA has less debt than IDYA: AURA (18.1M) vs IDYA (26.6M). IDYA has higher revenues than AURA: IDYA (7M) vs AURA (0).
AURAIDYAAURA / IDYA
Capitalization343M2.9B12%
EBITDA-107.51M-380.2M28%
Gain YTD-34.18531.128-110%
P/E RatioN/AN/A-
Revenue07M-
Total Cash177M670M26%
Total Debt18.1M26.6M68%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAIDYA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 7 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OANMX160.310.37
+0.23%
Oakmark Institutional
MITEX16.89N/A
N/A
Matthews Asia Innovators Institutional
GAHPX29.99N/A
N/A
Goldman Sachs Emerging Markets Eq P
FOBPX20.91-0.10
-0.48%
Tributary Balanced Instl Plus
OAIEX14.90-0.12
-0.80%
Optimum International A